user

Determinants of inhibitor development in previously treated hemophilia A patients

被引：0
|
作者：
Iorio, A. [1 ,2 ]
Barbara, A. [3 ]
Castaman, G. [4 ]
Fischer, K. [5 ]
Gilman, E. [6 ]
Goudemand, J. [7 ]
Kavakli, K. [8 ]
Kubicek-Hofmann, C. [9 ]
Lambert, T. [10 ]
Lissitchkov, T.
Makris, M. [6 ]
Matthew, P. [11 ]
Castelano, M. E. M.
Ozdemir, N.
Parra, R.
Peerlinck, K.
Rivolta, G. [12 ]
Romanov, V [13 ]
Roussel-Robert, V
Tagliaferri, A. [14 ]
Windyga, J. [15 ]
Zanon, E. [16 ]
机构：
[1] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada
[2] McMaster Univ, Med, Hamilton, ON, Canada
[3] McMaster Univ, Clin Epidemiol & Biostat, Hamilton, ON, Canada
[4] Azienda Osped Policlin Careggi, Florence, Italy
[5] Van Creveld Clin, Utrecth, Netherlands
[6] Univ Sheffield, Sheffield, S Yorkshire, England
[7] Univ Lille, Lille, France
[8] Unviers Izmir, Izmir, Turkey
[9] Univ Berlin, Berlin, Germany
[10] Univ Paris, F-75252 Paris, France
[11] Bayer, Pittsburgh, PA USA
[12] Policlin Univ, Parma, Italy
[13] Baxter Healthcare, Los Angeles, CA USA
[14] Policlin Univ, Parma, Italy
[15] Univ Warsaw, Warsaw, Poland
[16] Univ Padua Polyclin, Padua, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR144
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [31] Factor VIII prophylaxis and inhibitor development in previously untreated patients with severe hemophilia A: The RODIN study
    Gouw, S.
    Van den Berg, H.
    Van der Bom, J.
    HAEMOPHILIA, 2012, 18 : 89 - 89
  • [32] DETERMINING INHIBITOR-DEVELOPMENT RISK IN PREVIOUSLY UNTREATED HEMOPHILIA-A PATIENTS TREATED (PUPS) WITH RECOMBINANT FACTOR-VIII (RECOMBINATE(TM))
    LEE, ML
    COURTER, S
    GOMPERTS, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 856 - 856
  • [33] Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
    Masashi Taki
    Katsuyuki Fukutake
    Tadashi Matsushita
    Keiji Nogami
    Midori Shima
    Akira Yoshioka
    Junki Takamatsu
    Morio Arai
    Hiroshi Takagi
    Haruhiko Uchikawa
    Werner Engl
    Akira Shirahata
    International Journal of Hematology, 2019, 109 : 241 - 241
  • [34] Incidence of factor VIII inhibitor in Korean previously untreated hemophilia A patients
    Yoo, Ki Young
    Park, Young Shil
    Kim, Ji Yoon
    HAEMOPHILIA, 2018, 24 : 28 - 28
  • [35] COMBINATION OF EMICIZUMAB WITH SIM OCT OCOG ALFA FOR PROPHYLAXIS IN PREVIOUSLY UNTREATED/MINIMALLY TREATED HEMOPHILIA A PATIENTS, AND FOR MANAGING INHIBITOR PATIENTS
    Sidonio, R.
    Meeks, S. L.
    Shapiro, A.
    Manco-Johnson, M.
    Callaghan, M.
    HAEMATOLOGICA, 2019, 104 : 16 - 17
  • [36] Epidemiology of Factor VIII Inhibitor Development in Patients with Severe Hemophilia A Treated in our Institution
    Tahara, Teppei
    Ishida, Toshiaki
    Nakamura, Sayaka
    Fujiwara, Takahiro
    Tamura, Akihiro
    Yamamoto, Nobuyuki
    Kozaki, Aiko
    Saito, Atsuro
    Kishimoto, Kenji
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S115 - S115
  • [37] Immunogenicity of BAX 855 in Previously Treated Patients with Congenital Severe Hemophilia A
    Horling, Frank Michael
    Allacher, Peter
    Koppensteiner, Herwig
    Engl, Werner
    Scheiflinger, Fritz
    Abbuehl, Brigitt E.
    Reipert, Birgit M.
    BLOOD, 2016, 128 (22)
  • [38] Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia A
    Hyun, Shin Young
    Park, Soon Yang
    Lee, Soon Yong
    Kook, Hoon
    Paik, Sang Hoon
    Jang, In-Jin
    Lee, Kun Soo
    YONSEI MEDICAL JOURNAL, 2015, 56 (04) : 935 - 943
  • [39] Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?
    Messori, Andrea
    Fadda, Valeria
    Maratea, Dario
    Trippoli, Sabrina
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (02): : 269 - 270
  • [40] Inhibitor development against FVIII in previously treated patients with haemophilia A - A retrospective data collection
    Siegmund, B.
    Pollmann, H.
    Richter, H.
    Orlovic, M.
    Gottstein, S.
    Klamroth, R.
    HAMOSTASEOLOGIE, 2010, 30 (4A): : S37 - S39
12345